{CurrentPage:PageName}

About Us

ACO Name and Location

Covenant ACO, Inc.
Previous Legal Business Entity Name: Covenant Health Partners, Inc.
3615 19th St
Lubbock, Texas 79410

ACO Primary Contact

Primary Contact Name

Nathan Taylor

Primary Contact Phone Number

Primary Contact Email Address

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

Lubbock Medical Associates

N

C. Michel Oliva, M.D. PA

Y

Womens Health LLP

N

Grace Clinic of Lubbock

Y

Family First Healthcare Of Lubbock LLC

N

Justin McCarthy, MD, PA

N

West Texas Digestive Disease Center PA

N

Ronnelle S Burley PA

N

Lubbock Nephrology Associates, PA

N

Podiatric Medical Partners Of Texas, PA

N

Sergio Lara, MD, PA

N

High Plains Radiation Investments, LLC

N

Ear Nose and Throat Associates of Lubbock, PA

Y

High Plains Radiation Oncology, LLC

N

Priscilla Snodgrass, MD, PA

N

Elias Ghandour, MD

N

Manoj Khandheria MD

N

SWAT Surgical Associates, LLP

Y

Frank Ryburn

N

Christopher Rose

N

Samuel Spikes

N

Kirk J Tiemann, MD, PA

N

Cathy Malouf, MD

N

John Streit, MD, PA

N

Hal Green

N

Samuel Hale

N

William Boothe

N

James Gage

N

Lakhu Rohra

N

Family Foot And Ankle Care Pllc

N

Robert Ordonez, MD, PA

N

Kim Pershall, MD, PA

N

Ronnelle Burley

N

Lehman Dermatology Clinic, PA

N

Kumarapillai Narendran, MD

N

Frank M Ryburn III, MD

N

Alan D Row MD PA

N

Lubbock Digestive Disease Associates

N

Lubbock Kidney Blood Pressure Clinic PA

N

METHODIST HOSPITAL LEVELLAND

N

Associates For Pain Management P.A.

N

CSK Medical Partners

Y

Schwarzentraub Foot Clinic, PC

N

Elias Ghandour PA

N

METHODIST HOSPITAL, PLAINVIEW, TEXAS

N

William A. Shaver, MD, PA

N

Kim E Pershall MD PA

Y

John E Streit MD PA

Y

Sandra Dickerson MD PA

N

Neurosurgical Associates, LLP

N

James J Boop, MD, PA

Y

Covenant Medical Group

Y

West Texas Eye P A

Y

Lubbock Dermatology

N

Lubbock Diagnostic Radiology, L.L.P.

Y

Arthritis & Osteoporosis Associates, LLP

N

Christopher R. Rose, MD, PA

N

Lubbock Primary Care, PLLC

N

Owen Health Group, PLLC

N

Rodney T Franklin MD PA

Y

Susan Robertson Devine MD

N

ACO governing body:

Member

Member's Voting Power – Expressed as a percentage or number

Membership Type

ACO Participant Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Rose

Christopher

Chair

0

ACO Participant Representative

Christopher R. Rose, MD, PA

Snodgrass

Brad

Vice Chair

1

ACO Participant Representative

Covenant Medical Group

Backlund

Amanda

Member

1

ACO Participant Representative

Covenant Medical Group

Blan

David

Member

1

ACO Participant Representative

Covenant Medical Group

Devine

Susan

Member

1

ACO Participant Representative

Susan Devine, MD

Ferguson

Angela

Member

1

ACO Participant Representative

Covenant Medical Group

Fitz

Juan

Member

1

ACO Participant Representative

Covenant Medical Group

Gray

David

Member

1

ACO Participant Representative

Covenant Medical Group

Henderson

Richard

Member

1

ACO Participant Representative

Covenant Medical Group

Hensal

Frederick

Member

1

ACO Participant Representative

Covenant Medical Group

Kadiyala

Srinivas

Member

1

ACO Participant Representative

Covenant Medical Group

Kensing

Kelly

Member

1

ACO Participant Representative

Lubbock Digestive Disease Associates

Mangold

David

Member

1

ACO Participant Representative

Lubbock Surgical Associates, LLP

Patel

Nilesh

Member

1

ACO Participant Representative

Covenant Medical Group

Rohra

Lakhu

Member

1

ACO Participant Representative

Lakhu J. Rohra, MD

Wilks

Brenda

Member

1

Medicare Beneficiary Representative

N/A

Key ACO clinical and administrative leadership:

John Grigson

ACO Executive

Michael Robertson

Medical Director

Carl Winekoff

Compliance Officer

Nathan Taylor

Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Credentials Committee

Dr. Kelly Kensing, Chair

Population Health Committee

Dr. Nilesh Patel, Chair

Quality & Performance Committee

Dr. Frederick Hensal, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2017, $282, 266
  • First Agreement Period
    • Performance Year 2016, $2,659,327
    • Performance Year 2015, $0
    • Performance Year 2014, $2,542,945

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2017
      • Proportion invested in infastructure: 25%
      • Proportion invested in redesigned care processes/resources: 8%
      • Proportion of distribution to ACO participants: 66%
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 25%
      • Proportion invested in redesigned care processes/resources: 8%
      • Proportion of distribution to ACO participants: 66%
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: 25%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 50%

Quality Performance Results

2016 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

80.69

79.9

ACO-2

CAHPS: How Well Your Providers Communicate

94.03

92.63

ACO-3

CAHPS: Patients' Rating of Provider

93.59

91.93

ACO-4

CAHPS: Access to Specialists

86.64

83.52

ACO-5

CAHPS: Health Promotion and Education

58.36

60

ACO-6

CAHPS: Shared Decision Making

79.09

75.28

ACO-7

CAHPS: Health Status/Functional Status

71.09

71.82

ACO-34

CAHPS: Stewardship of Patient Resources

32.98

27.52

ACO-8

Risk-Standardized, All Condition Readmission

14.07

14.7

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

18.76

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

50.29

53.2

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

66.86

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

52.52

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

4.76

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

10.82

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

71.43

82.72

ACO-39

Documentation of Current Medications in the Medical Record

96.66

87.54

ACO-13

Falls: Screening for Future Fall Risk

77.91

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

75.81

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

70.81

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

91.62

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

96.19

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

70.06

53.63

ACO-19

Colorectal Cancer Screening

63.04

61.52

ACO-20

Breast Cancer Screening

80.18

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

90.03

76.84

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

81.12

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

20.97

18.24

ACO-41

Diabetes: Eye Exam

44.76

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

66.48

70.52

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

91.12

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

80.51

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

70.49

79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “Covenant ACO, Inc.” to view the quality performance results. This ACO can also be found by using the ACO ID A07425 in the public use files on data.cms.gov.

Payment Rule Waivers

  • Yes, our ACO does use the SNF 3-Day Rule Waiver and has entered into Post-Acute Care Affiliate Agreements with the following Skilled Nursing Facilities
    • Carillon LifeCare Community
    • Crown Point Health Suites
    • Garrison Nursing Home and Rehabilitation Center
    • The Plaza at Lubbock

Join Covenant Health Partners

Click Here
Join Covenant Health Partners